Investment Analysts’ Updated EPS Estimates for June 29th (ALKS, AMPH, ASML, BHVN, CER, CNMD, CREO, DH, DOCS, DUOL)
Investment Analysts’ updated eps estimates for Monday, June 29th: Alkermes (NASDAQ:ALKS) had its underperform rating reaffirmed by analysts at Bank of America Corporation. Amphastar Pharmaceuticals (NASDAQ:AMPH) had its underperform rating reaffirmed by analysts at Bank of America Corporation. The firm currently has a $20.00 target price on the stock, down from their previous target price […]
29 Jun 17:14 · The Markets Daily